PDLIM5
Basic information
Region (hg38): 4:94451857-94668227
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDLIM5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 31 | 3 | 2 |
Variants in PDLIM5
This is a list of pathogenic ClinVar variants found in the PDLIM5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-94456255-G-A | Likely benign (Oct 01, 2023) | |||
4-94523730-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
4-94523736-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
4-94523769-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
4-94523850-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
4-94573370-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
4-94575693-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
4-94575713-G-A | not specified | Uncertain significance (Aug 28, 2023) | ||
4-94575713-G-T | not specified | Uncertain significance (Nov 18, 2022) | ||
4-94575715-C-A | not specified | Uncertain significance (Dec 26, 2023) | ||
4-94575730-T-G | not specified | Uncertain significance (Jul 05, 2023) | ||
4-94575764-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
4-94575767-C-G | not specified | Uncertain significance (Sep 28, 2021) | ||
4-94575788-C-T | not specified | Uncertain significance (Aug 08, 2023) | ||
4-94575789-G-A | Benign (Jul 11, 2018) | |||
4-94575829-G-A | not specified | Uncertain significance (Jan 11, 2023) | ||
4-94575910-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
4-94575923-C-A | not specified | Uncertain significance (Jun 29, 2022) | ||
4-94585582-T-C | not specified | Uncertain significance (Mar 16, 2022) | ||
4-94585590-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
4-94585606-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
4-94585621-A-G | not specified | Uncertain significance (Dec 18, 2023) | ||
4-94585669-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
4-94585671-C-A | not specified | Uncertain significance (Aug 22, 2023) | ||
4-94618024-C-T | not specified | Uncertain significance (Apr 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDLIM5 | protein_coding | protein_coding | ENST00000514743 | 16 | 216341 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00168 | 0.998 | 125718 | 0 | 27 | 125745 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.679 | 294 | 329 | 0.895 | 0.0000168 | 4043 |
Missense in Polyphen | 101 | 132.68 | 0.76123 | 1653 | ||
Synonymous | 1.12 | 102 | 117 | 0.868 | 0.00000626 | 1222 |
Loss of Function | 3.55 | 11 | 33.0 | 0.334 | 0.00000164 | 414 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000262 | 0.000262 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000116 | 0.000114 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000134 | 0.000131 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play an important role in the heart development by scaffolding PKC to the Z-disk region. May play a role in the regulation of cardiomyocyte expansion. Overexpression promotes the development of heart hypertrophy. Contributes to the regulation of dendritic spine morphogenesis in neurons. May restrain postsynaptic growth of excitatory synapses (By similarity). {ECO:0000250}.;
- Pathway
- miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.852
Intolerance Scores
- loftool
- 0.681
- rvis_EVS
- 1.34
- rvis_percentile_EVS
- 94.25
Haploinsufficiency Scores
- pHI
- 0.212
- hipred
- N
- hipred_score
- 0.306
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.546
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdlim5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype;
Gene ontology
- Biological process
- regulation of synapse assembly;regulation of dendritic spine morphogenesis;cell growth involved in cardiac muscle cell development;cell-cell adhesion
- Cellular component
- cytosol;cell-cell adherens junction;postsynaptic density;actin cytoskeleton;membrane;neuron projection;postsynaptic membrane
- Molecular function
- actin binding;protein kinase C binding;protein binding;actinin binding;metal ion binding;protein N-terminus binding;cadherin binding involved in cell-cell adhesion